Abstract-Pro-inflammatory cytokines induced by inflammation and iron accumulation in the substantia nigra (SN) have been implicated in the pathogenesis of Parkinson's disease (PD). In the present study, we aimed to investigate the relationship between inflammation and iron accumulation in a lipopolysaccharide (LPS)-induced Parkinsonian rat model. The activation of glial cells and elevated levels of pro-inflammatory cytokines were observed in the SN of LPS models, accompanied by iron deposits in the same region. Moreover, ferroportin (Fpn), the only channel for iron export, was downregulated. SH-SY5Y dopaminergic cells were pre-incubated with conditioned media enriched in pro-inflammatory cytokines, and abnormal iron deposits and a drop of Fpn were observed. The expression of heme oxygenase-1 (HO-1) was also upregulated in vivo and in vitro. These results suggested that pro-inflammatory cytokines might induce Fpn downregulation, which leads to iron accumulation and dopaminergic neurons' degeneration in PD. HO-1 may also contribute to the iron accumulation in neurons, but its mechanism needs to be further investigated.
INTRODUCTION
Neuroinflammation and oxidative stress are recognized as pathological features of Parkinson's disease (PD) (Jessica et al., 2012; Saurabh and Kalipada, 2012) . Increasing evidence supports the idea that glial cell activation is the main source of inflammation contributing to nigral dopaminergic cell degeneration in PD (Lin et al., 2007; Jessica et al., 2012; Saurabh and Kalipada, 2012) . Increasing levels of serum tumor necrosis factor-a (TNFa), interleukin (IL)-6 and IL-1 were observed in PD patients, and pro-inflammatory cytokines secreted from glial cells had a damaging effect on neurons (Toyoko and Guoying, 2003; Ruth et al., 2010) .
Iron accumulation has been suggested as being involved in the pathogenesis of PD (Randy et al., 2008; Glenda et al., 2011; Sian et al., 2011; Van den Berge et al., 2012) . The mechanism responsible for iron accumulation in neurodegeneration may be abnormal iron homeostasis (Richard et al., 2007; Zhanyun et al., 2011) . Increasing level of tissue iron may generate reactive oxygen species by engaging in Fenton and other reactions (Schipper, 2004a,b,c) . Oxidative stress induced by reactive oxygen or nitrogen species mediated by iron causes the cellular destruction. Moreover, these pathogenic mechanisms seem to be closely correlated to the cascade of events resulting in cellular death (Ning et al., 2010; Jeswinder et al., 2011; Jia et al., 2013) .In recent years, some iron chelators have been under preclinical investigation and are used in human trials as future treatments for PD (Orly et al., 2013) . However, the mechanism that induces iron deposition in neurons has yet to be elucidated.
Iron and inflammatory genes were both altered in human substantia nigra (SN) from the post-mortem brain tissue of PD patients, which indicated that iron and inflammation play important roles in the pathogenesis of PD (Gru¨nblatt et al., 2004) . Under inflammatory conditions, changes in the gene expression of iron regulatory factors occur (She et al., 2002; Nobuhiko et al., 2011; Stefania et al., 2012) . Iron enters the reticuloendothelial system to minimize the concentration of this essential element in circulation (Nadeem et al., 2007; Stefania et al., 2010; Rachel et al., 2011) . However, the mechanism of iron in the brain is poorly understood because the blood/brain barrier exists between the CNS and plasma iron pool (Zhang et al., 2005a,b; Randy et al., 2008) .
In this study, we have measured the iron deposition in a lipopolysaccharide (LPS)-induced Parkinsonian rat model. To explore the mechanism implied in abnormal iron deposits, the concentration of pro-inflammatory cytokines, the expression of ferroportin (Fpn) and heme oxygenase-1 (HO-1) were detected. In vitro, SH-SY5Y cells were treated with conditioned media (CM) and pro-inflammatory cytokines respectively. Ironrelated factors were also detected to investigate the mechanism in iron accumulation under inflammatory conditions.
EXPERIMENTAL PROCEDURES Animal model and surgery
Forty male Sprague-Dawley rats (purchased from Animal Center of the Shandong University of Traditional Chinese Medicine) weighing between 180 and 200 g are used. Animals were grouped four or five in a cage and located in a standard environment with controlled temperature and humidity. They were housed under a reversed light-dark rhythm (light off from 07:00 to 19:00 h) and water and food was provided ad libitum. After arrival, they were given at least 10 days for adaptation before surgery. All procedures were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and were approved by the Animal Ethics Committee of the Qingdao University.
Animals were anesthetized with 400 mg/kg 8% chloral hydrate (shanghai, Zhanyun Chemical Co., Ltd., China). The rats were placed in a BENCH mark stereotaxic frame; the scalp was cut and retracted to expose the skull. Aiming at the left SN, all animals received unilateral administration of 2 ll LPS (5 lg/ll) into the left SN at the following co-ordinates, AP: À4.8 mm, L: 2.0 mm, V: À7.6 mm according to the rat brain atlas of Paxinos and Watson. The cannula was left in place for 5 min to prevent a reflux. Finally, the scalp was sutured and 70% ethanol was applied for disinfection. Placebo animals received saline injections into the left striatum with the same regimen.
Use of anti-inflammatory agent of sodium salicylate (SS). Another group was injected with SS (obtained from Sigma-Aldrich, St. Louis, MO, USA) intraperitoneally at a dose of 100 mg/kg body weight and/or the LPS (10 lg) administration in the SN. Then, brain tissue was obtained for Western blot assay of Fpn and HO-1 at 1 day after administration.
Immunohistochemical detection of tyrosine hydroxylase (TH) and hematoxylin and eosin (HE) stain
Dopaminergic neurons were detected with a rabbit polyclonal antibody against TH, the rate-limiting enzyme in dopamine synthesis, used at dilution of 1:200 (Santa Cruz Biotechnology, Inc., USA). The staining was performed on free-floating nigral sections. Briefly, sections were washed in (pH 7.4) phosphate-buffered saline (PBS). Endogenous peroxidase activity was blocked by incubating the sections in 1% hydrogen peroxide/PBS for 30 min. After three washes in PBS, non-specific binding was blocked with 20% normal goat serum in 0.1 M PBS for 1 h. Sections were then incubated in anti-TH primary antibody in PBS containing 0.05% triton X-100 and 2% normal goat serum overnight at 4°C. A secondary biotinylated goat anti-rabbit IgG was applied for 1 h at 18-20°C in PBS containing 0.05% triton X-100. This was followed by incubation with ABC Elite peroxidase staining kit. TH-positive cell bodies were counted by using the Stereo Investigator analysis software (VIDAS2.0, Germany), combined with a Nikon Elipse E600 microscope and a CX900 video camera (ZEISS, Germany). Results were expressed as percentage of TH-positive cells in the ipsilateral SN with respect to the contralateral side. Animals per group were as follows:
control: injection of saline in the SN 2 lL for 14 days; LPS (14 d) group: injection of LPS 2 lL in the SN for 14 days.
We performed a HE staining to study the inflammatory infiltration. Sections were mounted onto slides, passed through ethanol 96°, ethanol 70°, stained with cresyl violet, and passed through two ethanol 96°, two ethanol 100°and three xylenes.
Modified Perl's iron stain
Briefly, sections were rinsed with PBS and incubated for 30 min at room temperature with a 1:2:1 ratio of 4% potassium ferrocyanide, 2% Triton X-100, and 0.5 N HCl respectively. The sections were then washed in PBS and incubated for 12-15 min in 0.2 mg Diaminobenzidine (DAB) per ml of 0.01 M Tris-HCl, pH 7.4, with 0.06% H 2 O 2 . Sections were rinsed in PBS, immersed in a gelatin solution and mounted on a slide before being dehydrated and cover slipped using Permount (Fisher Scientific, Germany).
Perl's iron stain
For Perl's staining, sections were processed through a series of graded alcohols, into xylene, and rehydrated back to water. Sections were incubated in a 1:1 solution of 2% HCl and potassium ferrocyanide (Sigma-Aldrich, St. Louis, MO, USA) for 30 min and rinsed in water. Sections were counterstained with Neutral Red, dehydrated in increasing concentrations of ethanol, cleared in xylene, and mounted on slides.
TNF-a, IL-1 and IL-6 assay TNF-a, IL-1 and IL-6 were measured with immunosorbent assay kits from RD company. The media were assayed according to the manufacturer's protocol for the presence of TNF-a or IL-1b or IL-6 and quantified using an eight-point standard curve. The assay had a detection limit of 5 pg/ml.
Cell treatment
Human glioma cell lines were purchased from the Shanghai Medicine Institute and human dopaminergic neuroblastoma cell lines, SH-SY5Y were obtained from the Peking Union Medical College. Briefly, the cells were maintained at 37°C in Dulbecco's modified eagle medium (DMEM) supplemented with 10% FBS, 50 U/ml penicillin and 50 lg/ml streptomycin in a humidified incubator with 5% CO 2 and 95% air. A quantity of 1 Â 10 6 glioma cells/ml was seeded in six-well plates.
After 24 h, the cells were treated with 20 lg/mL of LPS.
LPS (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in saline solution and was used at a final concentration of 20 lg/ml for 8, 12 and 24 h, respectively. After indicated times, the plates were centrifuged in order to remove the detached cells from the medium, and the supernatant was collected and used as CM for further study. CM0, CM8, CM12, and CM24 represented CM from glioma cell line cultures treated with saline, 20 lg/ mL LPS 8, 12 and 24 h, respectively. SH-SY5Y cells cultured in plates and dishes until $70% confluence were used for treatment. At the time of treatment, the culture medium was replaced with CM from glioma cultures. After being treated with CM for 24 h, cells were measured for indexes.
Pro-inflammatory cytokines treatment
SH-SY5Y cells were treated for 24 h with saline; 10 ng/mL TNF-a; 10 ng/mL IL-6 or 10 ng/mL TNF-a + 10 ng/mL IL-6. All cultures were loaded with iron by incubating with 20 lM FeCl 3 . TNF-a and IL-6 (both from R&D Systems Inc. Minneapolis, MN, USA), then iron deposit was measured by modified Perl's iron stain and Fpn and HO-1 were measured via Western blot assay. 
Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from cells by TRIzol reagent (Sigma-Aldrich, St. Louis, MO, USA) and purified with RNase columns (Fermentas, CA, USA). Expression of the selected genes was quantified using real-time RT-PCR analysis. The synthesized cDNA was used for PCR amplification with SYBR Green I PCR kit (QIAGEN, Valencia, CA, USA) as recommended by the manufacturer. The reaction was carried out in a Smart Cycler Real-Time PCR apparatus (GeneAmp2400, PE). The forward and reverse primers for HO-1 genes were 5 0 -TCAACATCCAGCTCTTTGAGGA and 5 0 -AGTGTAAG GACCCATCGGAGAA. The forward and reverse primers for Fpn gene were 5 0 -CGCCTACACTCAGGGACT and 5 0 -GACCGATTCTAGCAGCAAT. The forward and reverse primers for b-actin (mark gene) were 5 0 -ATCATGTTTGAGACCTTCAACA and 5 0 -CATCTCTT GCTCGAAGTCCA. PCR reaction was initiated at 95°C for 5 min, followed by 32 cycles of 94°C for 30 s, 56°C for 30 s, and 72°C for 30 s, and a final extension at 72°C for 10 min. Each reaction was repeated three times. The relative differences in expression between groups were expressed using cycle time (Ct) values and the relative differences between groups were expressed as relative increases setting the control as 100%. Assuming that the Ct value is reflective of the initial starting copy and that there is 100% efficacy, a difference of one cycle is equivalent to a twofold difference in the starting copy.
Western blot analysis
The detection for Fpn protein expression was measured by Western blotting method. Following the LPS treatment, cells or frozen tissues were washed with icecold PBS and lysed with RIPA buffer (Sigma-Aldrich, St. Louis, USA). The cell lysates were centrifuged at 12,000g for 10 min at 4°C. Protein contents were determined using the Bradford method. Twentymicrogram aliquots plus 6Â sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) loading buffer (300 mM Tris-HCl pH 6.8, 600 mM DLDithiothreitol (DTT), 12% SDS, 0.6% bromophenol blue, 60% glycerol) were subjected to 12% SDS-PAGE and transferred to the polyvinylidene fluoride membranes. Nonspecific binding was blocked by incubation in Tris buffer saline (pH 7.4) containing 3% nonfat milk and 0.1% Tween 20 for 1 h at room temperature. Blots were probed with anti-HO-1 polyclonal antibody (1:200 diluted), anti-Fpn monoclonal antibody (1:500 diluted) and anti-b-actin monoclonal antibody (1:200 diluted). The secondary antibody consisted of horseradish peroxidase-conjugated goat anti-human or rat antibody (1:500 diluted). Protein bands were visualized by enhanced chemiluminescence using ECL. Western blotting reagents. All antibodies were obtained from Santa Cruz Biotechnology, CA, USA and Boster BioEngineering Co., Ltd. Wuhan, China, but Fpn antibody was from Sigma-Aldrich, St. Louis, USA.
Statistical analysis
Results are presented as means ± SEM. Differences between means in two groups were carried out by unpaired-samples t-test. One-way analysis of variance (ANOVA) followed by Student-Newman-Keuls test was used to comparing difference between means in more than two groups. Differences at p < 0.05 were considered as statistically significant.
RESULTS

Activation of glial cells, secretion of inflammatory cytokines and the loss of dopaminergic cells in the SN
A single intranigral injection of LPS ((5 lg/2 ll saline) led to a significant decrease in the number of dopaminergic neurons in the SN. About 63% dopaminergic cells were lost in the SN. (0.99 ± 0.12 vs. 0.36 ± 0.14, P < 0.001; Fig. 1) .
To study the inflammatory response to LPS's administration in the SN, we performed an HE stain for inflammatory infiltration (Fig. 2) . The results showed that glial cells were activated around the LPS-injected site. Neuroinflammation is suggested to be the major cause of the loss of dopaminergic neurons in PD animal models and patients. Using an enzyme-linked immunosorbent assay (ELISA) assay, the expressions of TNF-a, IL-6 and IL-1 were measured 1 d after LPS injection. As shown in Fig. 3 , LPS led to a notable increase in the expressions of IL-6 (70.5 ± 7 pg/ml vs. 21.5 ± 2.8 pg/mL, P < 0.001) and IL-1 (82.3 ± 4.5 pg/ ml vs. 21.5 ± 4.1 pg/mL, P < 0.001) in SN, but no remarkable increase was observed in the level of TNF-a (30.7 ± 9.6 pg/ml vs. 23 ± 3.8 pg/ml, P > 0.05; Fig. 3 ).
Iron deposits and the expression of Fpn and HO-1 in the SN
To detect the iron accumulation under inflammation conditions in PD, iron deposits were measured using Perl's method in the SN. The results showed the number of iron stain-positive cells increased several folds in activated glial cells in the SN (2 ± 1.9 vs. 18 ± 1.8, P < 0.001. Fig. 4) , suggesting that the iron deposits correlated with the inflammatory response induced by LPS.
Because abnormal iron deposits were observed in SN in the present study, they were suggested to result from the shift of iron homeostasis. The expression of Fpn related to iron metabolism was detected at 1 and 14 d after the LPS administration via the Western blot method (Fig. 5) . Fpn is directly involved in brain cell iron traffic. The level of Fpn fell significantly after the LPS was administered to the SN, ranging from 0.93 ± 0.14 to 0.65 ± 0.08, P < 0.001. The level of HO-1 was upregulated at 1 d after the LPS administration (0.63 ± 0.07 vs. 0.26 ± 0.06, P < 0.001), but returned to the normal level after 14 days (0.33 ± 0.04 vs. 0.26 ± 0.06, P > 0.05; Fig. 5 ).
Expression of Fpn and HO-1 was measured after use of anti-inflammatory agent of SS. There was less than 10% decrease in the level of Fpn (0.95 ± 0.19 vs 0.87 ± 0.01, P < 0.05) and 50% increase in the level of HO-1 (0.26 ± 0.01 vs 0.16 ± 0.02, P < 0.001). Results in Fig. 6 showed SS delayed the decline of Fpn and upregulation of HO-1 compared to the LPS group.
Level of TNF-a and IL-6 in culture of LPS-activated glioma cells
In this study, the activation of glial cells was accompanied by increasing levels of pro-inflammatory cytokines in the SN in a LPS-induced PD rat model. To discover the mechanism of pro-inflammatory cytokines in iron accumulation, 20 lg/mL LPS was chosen for the activation of glioma cells. Glioma cells, which have the characteristics of astrocytes (Hey et al., 2010) , were selected in order to produce the CM enriched in pro-inflammatory cytokines. To evaluate the level of pro-inflammatory cytokines released from the glioma cells, the concentration was detected using ELISA. Measurements were taken at 8, 12 and 24 h after cells were treated with 20 lg/mL LPS.
As shown in Fig. 6 , the level of pro-inflammatory cytokines of TNF-a (2.75 ± 0.57 ng/mL, 5.2 ± 0.6 ng/ mL, 6.18 ± 0.67 ng/mL vs. 0.4 ± 0.05 ng/mL, P < 0.001) and IL-6 (71 ± 14.8 pg/mL, 177 ± 30.4 pg/ mL, 304 ± 24.8 pg/mL vs. 25 ± 7 pg/mL, P < 0.001) increased in a time-dependent manner (Fig. 6) .
Apoptosis of dopaminergic cells treated with CM rich in pro-inflammatory cytokines
SH-SY5Y was a dopaminergic neuron. After being treated with CM0, CM8, CM12 and CM24 with various concentrations of pro-inflammatory cytokines for 24 h, the percentage of apoptotic cells was measured via flow cytometry in SH-SY5Y cells. As seen in Fig. 7 , the percentage of annexin V-positive cells, an indicator of early apoptosis, was greater in the groups treated with the CM8, CM12 or CM24. The value of apoptosis increased with the concentration of pro-inflammatory cytokines in CM (Fig. 7) .
Iron deposits and the expression of Fpn and HO-1 in dopaminergic cells
To analyze the action of inflammatory reaction on iron deposits in dopaminergic cells, iron deposits were measured with a modified Perl's iron stain method ( Fig. 8) . The value of iron stain-positive cells (0.20 ± 0.049 vs. 0.11 ± 0.02, P < 0.05) went up after treatment with CM rich in pro-inflammatory cytokines.
To explore the mechanism of iron accumulation in dopaminergic cells, the expression of Fpn was measured via qPCR and the Western blot method (Fig. 9) . The protein expression of Fpn dropped significantly in the CM24 group (0.99 ± 0.09 vs. 0.80 ± 0.07, P < 0.05). At the mRNA level, HO-1 was upregulated about 2.5 folds compared with the control group (73 ± 4.1% vs. 27 ± 2.3%, P < 0.001). The same trend was seen on the protein expression of HO-1 by the Western blot method (0.77 ± 0.08 vs. 0.19 ± 0.04, P < 0.001; Fig. 9 ).
To ascertain if the pro-inflammatory cytokines result in the iron deposit in neurons, we evaluated the iron deposit in neurons treated with TNF-a; IL-6 or both and iron loading. After 24-h treatment, iron deposit increased significantly in pro-inflammatory cytokine groups (0.22 ± 0.02; 0.020 ± 0.018; 0.24 ± 0.028 vs. 0.16 ± 0.03, P < 0.01. Fig. 10 ). The result was consistent with the previous publications (Jia et al., 2013; Urrutia et al., 2013 ). Then we evaluated if the increase in iron deposit induced by pro-inflammatory cytokines was associated with iron regulatory factors such as HO-1 and Fpn. The SH-SY5Y cells treated with pro-inflammatory cytokines presented a significant twoor threefold increase in HO-1 protein content (0.337 ± 0.054, 0.302 ± 0.047, 0.59 ± 0.08 vs. 0.188 ± 0.03, P < 0.001) and 25-30% decrease in Fpn protein level (0.70 ± 0.08, 0.71 ± 0.07, 0.65 ± 0.08 vs. 0.97 ± 0.12, P < 0.01; Fig. 11 ).
DISCUSSION
The present study showed iron accumulation in SN in a LPS-induced Parkinsonian rat model, accompanied by the activation of glial cells (Jens et al., 2009; Julie et al., 2012) , a remarkable rise in pro-inflammatory cytokines such as IL-1 and IL-6 and the loss of dopaminergic cells in the SN. via the Western blot method, Fpn was downregulated in the SN, which may account for the iron accumulation in PD. To our knowledge, few reports about the relationship between inflammation and iron accumulation in PD exist (see Fig. 12 ).
To explore the relationship between inflammatory stimuli and iron accumulation, we observed iron accumulation in LPS-induced PD rat model and in vitro. In PD rat model, iron deposition, activated glial cells and remarkable rise of pro-inflammatory cytokines of IL-1 and IL-6 were observed in the SN. Data showed inflammatory stimuli induced iron deposits in liver and brain during acute-phase response (Ihtzaz et al., 2011) . However, there was a study that showed iron deposition was independent of cellular inflammation in a cerebral model of multiple sclerosis (Rachel et al., 2011) . Some studies revealed cytokines and LPS can cause iron retention by modulating iron-related genes in human monocytic cells (Susanne et al., 2003) . Iron-related factors such as Fpn and HO-1 were also measured in our study. Use of anti-inflammatory agent of SS strengthened the relationship between inflammation and iron accumulation. We suggested that iron deposition in the SN may be caused by expressive alteration of some iron-related factors mediated by pro-inflammatory cytokines. To test the relationship between pro-inflammatory cytokines and iron accumulation in neurons, we performed experiments in vitro. Neuroblastoma, SH-SY5Y cells (dopaminergic cells) were exposed to the CM enriched in pro-inflammatory cytokines from LPSstimulated glioma cells or to the culture by adding proinflammatory cytokines of TNF-a and IL-6,respectively. The results showed pro-inflammatory cytokines can induce iron retention in cytosol via modulating the expression of Fpn and HO-1. Being the major iron exporter, Fpn has a central role in iron metabolism. In a previous study, Fpn levels were found to drop in the SN Fig. 8 . Apoptosis of dopaminergic cells after being treated with CM. After the dopaminergic cells settled down, we replaced the culture with CM with various concentrations of pro-inflammatory cytokines. (A-D) showed cell apoptosis and necrosis was detected by flow cytometry in CM0, CM8, CM12 or CM24, respectively; it was shown that the early apoptosis (AV(+)/PI(À)) increased with the dose of pro-inflammatory cytokines in CM. The results are shown in Table 1 . Values are the mean ± SEM for three independent experiments. * P < 0.001 compared with the sum of AV(+)/PI(À) for the CMO group.
of a 6-OHDA-induced Parkinsonian rat model (Wang et al., 2007) . The overexpression of Fpn can attenuate the iron retention and apoptosis of dopaminergic cells (Ning et al., 2010) . In our study, the protein level of Fpn was down-regulated in SN after LPS administration that was accompanied by the secretion of pro-inflammatory cytokines of IL-1 and IL-6. Another iron-related gene HO-1 was also measured in the study. The level of HO-1 increased remarkably right after the administration of LPS in the SN of rat model, but returned to the normal level after 14 days. In addition, expression of HO-1 was observed to rise up several folds in SH-SY5Y cells pre-incubated with proinflammatory cytokines in cultures. HO-1 is a ratelimiting enzyme to catalyze the degradation of heme, which produces biliverdin, carbon monoxide and ferrous iron (Schipper et al., 1998; Schipper, 2004a,b,c) . HO-1 is induced by oxidative stressors and play a protective role on neural cells (Ham and Schipper, 2000) . But it is a double-edged sword, overexpression of HO-1 has a nerve damaging effect (Elena et al., 2010) . It was reported recently that the overexpression of HO-1 increased the iron accumulation in neurons (Schipper et al., 1998; Lin et al., 2007) . In the present study, the remarkable increase of the expression of HO-1 was observed in SH-SY5Y cells, which did not cause the corresponding upregulation of the iron accumulation in cytosol. Ferrous iron, the second product of heme decomposition, may incorporate with simultaneously upregulated ferritin. So we suggested HO-1 may be involved in the iron metabolism, but might not be the crucial player. ( 
CONCLUSION
In summary, iron deposits accompanied by reactivated glial cells and the secretion of pro-inflammatory cytokines were observed in a LPS-stimulated Parkinsonian rat model. Down-regulation of Fpn and a remarkable rise of HO-1 mediated by pro-inflammatory cytokines may be involved in the iron accumulation in neurons. 
